Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avantor, Inc. Common Stock (NY:AVTR)

11.59 +0.09 (+0.74%)
Streaming Delayed Price Updated: 1:34 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Avantor, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Readystate Asset Management Takes a Giant Step Back From Lab Materials Stock
Readystate Asset Management Takes a Giant Step Back From Lab Materials Stock 
Via The Motley Fool
Topics Economy Regulatory Compliance
Wilson Asset Eliminates Stake In 805K AVTR Shares Valued At $10.8 Million
Wilson Asset Eliminates Stake In 805K AVTR Shares Valued At $10.8 Million 
Via The Motley Fool
Topics Supply Chain
3 Cash-Producing Stocks That Fall Short
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
The 5 Most Interesting Analyst Questions From Avantor’s Q3 Earnings Call
Avantor’s third quarter results were met with a significant negative market reaction, reflecting investor concerns surrounding both the scale and persistence of operational headwinds. Management... 
Via StockStory
Topics Earnings Economy
Earnings Scheduled For October 29, 2025
 
Via Benzinga
Avantor's Earnings Outlook
 
Via Benzinga
Is Avantor Stock a Buy After the Incoming Chairman of the Board Purchased Shares Worth Over $1 Million?
Is Avantor Stock a Buy After the Incoming Chairman of the Board Purchased Shares Worth Over $1 Million? 
Via The Motley Fool
Topics Economy Regulatory Compliance
Greenhaven Backs Avantor to Capture the Next Cycle in Life Sciences
Greenhaven Backs Avantor to Capture the Next Cycle in Life Sciences 
Via The Motley Fool
Avantor (AVTR) Stock Trades Up, Here Is Why
Shares of life sciences company Avantor (NYSE:AVTR) jumped 4.8% in the afternoon session after a director purchased a significant amount of company stock, signaling strong insider confidence. 
Via StockStory
1 Healthcare Stock with Impressive Fundamentals and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
What Analysts Are Saying About Avantor Stock
 
Via Benzinga
AVTR Q3 Deep Dive: Strategic Overhaul Launched Amid Margin and Execution Challenges
Life sciences company Avantor (NYSE:AVTR) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5.3% year on year to $1.62 billion. Its non-GAAP profit of $0.22 per share was... 
Via StockStory
Topics Economy
Stocks Slide As Powell Cools Rate-Cut Hopes: These 15 Stocks Are Feeling The Pinch
Stocks fell as Fed Chair Powell warned a December rate cut is uncertain, citing data gaps and policy division. 
Via Benzinga
Topics Economy
Avantor Plummets 17.4% as Disappointing Q3 Results and Impairment Charge Rock Investor Confidence
Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
Why Avantor (AVTR) Shares Are Trading Lower Today
Shares of life sciences company Avantor (NYSE:AVTR) fell 17.4% in the afternoon session after the company reported disappointing third-quarter 2025 results that missed revenue expectations and included... 
Via StockStory
Topics Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Avantor Struggles With Soft Demand But Backs Long-Term Value Through Buyback
Avantor stock fell after Q3 earnings and revenue missed estimates, leading the company to cut 2025 guidance but approve a $500 million buyback. 
Via Benzinga
Avantor Inc (NYSE:AVTR) Stock Plummets 17% After Q3 Revenue Miss
Avantor's Q3 2025 results missed revenue expectations, causing a sharp stock drop. While earnings per share met targets, sales fell 5.3% year-over-year. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Avantor (NYSE:AVTR) Misses Q3 Sales Expectations, Stock Drops 17.9%
Life sciences company Avantor (NYSE:AVTR) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5.3% year on year to $1.62 billion. Its non-GAAP profit of $0.22 per share was... 
Via StockStory
Earnings To Watch: Avantor (AVTR) Reports Q3 Results Tomorrow
Life sciences company Avantor (NYSE:AVTR) will be announcing earnings results this Wednesday before market open. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Avantor (AVTR) Stock Trades Up, Here Is Why
Shares of life sciences company Avantor (NYSE:AVTR) jumped 2.9% in the afternoon session after Bank of America Securities maintained its "Buy" rating on the company. This followed a similar move from... 
Via StockStory
Topics Artificial Intelligence
Avantor (AVTR): Buy, Sell, or Hold Post Q2 Earnings?
Since April 2025, Avantor has been in a holding pattern, posting a small return of 2.3% while floating around $15.30. The stock also fell short of the S&P 500’s 30.6% gain during that period. 
Via StockStory
Topics Stocks
Avantor (AVTR) Stock Is Up, What You Need To Know
Shares of life sciences company Avantor (NYSE:AVTR) jumped 4.9% in the afternoon session after sentiment towards the stock improved following a series of positive developments, including an analyst... 
Via StockStory
Topics Government
Research Tools & Consumables Stocks Q2 Recap: Benchmarking Avantor (NYSE:AVTR)
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Avantor (NYSE:AVTR) and its peers. 
Via StockStory
Topics Economy
Deep Dive Into Avantor Stock: Analyst Perspectives (11 Ratings)
 
Via Benzinga
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma
Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility
As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move... 
Via MarketMinute
Topics Economy Government Supply Chain
Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory
Topics Government
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.